Dong Sung Pharmaceutical’s Chairman Lee Yang-gu has filed an injunction to suspend the duties of CEO Na Won-gyun and directors Won Yong-min and Namgung Kwang. The injunction aims to prevent CEO Na from performing his duties until a final judgment is made and to appoint Kim, Lee, and Yoo as acting officers. This move is seen as an attempt to block the issuance of new shares through a third-party allocation method by CEO Na, which could dilute Chairman Lee’s shareholding.
Original Article: Read More
Auto-posted at: 2025-05-13 21:01:12